Variation in Endpoints for FDA Approved Migraine Therapies
Neurology Minute · Anna Rehbein
September 7, 20231m 40s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr. Leigh Sharpless discusses her paper, "Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications".
Show References: https://n.neurology.org/content/101/10/e989
https://directory.libsyn.com/episode/index/id/27962343